Results and prospects of development of new polyphenolic drugs for cancer patients
Autor: | I.A. Baldueva, Tea Kirkegaard Nielsen, Stig Larsen, Elena I. Fedoros, Alexander M. Scherbakov, Andrey V. Panchenko, Evgeny Yu Drobyshev, Vladimir N. Anisimov, Anastasia V Malek, Stig Lofberg, Alexey M. Belyaev, V.N. Bykov, Irina V. Perminova |
---|---|
Rok vydání: | 2017 |
Předmět: |
medicine.medical_specialty
Cancer chemotherapy Meeting Report 010501 environmental sciences 01 natural sciences cancer chemotherapy Breast cancer breast cancer medicine cancer polyphenols Cancer 0105 earth and related environmental sciences business.industry 010401 analytical chemistry Polyphenols clinical trial medicine.disease 3. Good health 0104 chemical sciences Biotechnology Clinical trial Oncology Family medicine business |
Zdroj: | OncoTarget Oncotarget Anisimov, V N, Larsen, S, Lofberg, S, Baldueva, I A, Malek, A V, Nielsen, T K, Fedoros, E I, Perminova, I V, Drobyshev, E Y, Bykov, V N, Panchenko, A V, Scherbakov, A M & Belyaev, A M 2017, ' Results and prospects of development of new polyphenolic drugs for cancer patients ', OncoTarget, vol. 8, no. 59, pp. 100951-100956 . https://doi.org/10.18632/oncotarget.22307 |
ISSN: | 1949-2553 |
DOI: | 10.18632/oncotarget.22307 |
Popis: | The conference "Results and prospects of development of new polyphenolic drugs for cancer patients" took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development and evaluation of medicinal products based on the novel lignin-derived soluble polyphenolic polymer BP-Cx-1. BP-Cx-1 is the platform for a portfolio of innovative pharmacological products such as BP-C1, BP-C2 and BP-C3. |
Databáze: | OpenAIRE |
Externí odkaz: |
načítá se...